Logo

OpiCalc

FavoritesSpecialtiesDrugsGuidelinesMost Used

All Specialties

OpiCalc Logo
FavoritesSpecialtiesDrugsGuidelinesMost Used
FavesSpecsDrugsGuidesTop
APGAR ScoreAssisted Delivery (FIGO)BPP (Manning Score)Bishop ScoreCARPREG II Cardiac RiskCervical Cancer StagingContraceptive Pearl IndexDoppler Matrix (UA/MCA)EFW (Hadlock)Endometrial StagingEndometrial ThicknessFGR Criteria (Consensus)FSFI (Sexual Function)Ferriman-Gallwey ScoreFetal Anemia (MCA PSV)GDM Diagnostic CriteriaGPA History IndicatorGail Model Breast RiskGestational Dating (LMP)HIV PMTCT ProtocolIOTA Simple RulesIVF Due Date & AMHIron Deficit (Ganzoni)Labour Progress (WHO)Maternal Sepsis (qSOFA)O-RADS ClassificationOvarian Cancer StagingPAS Hemorrhage RiskPPH Protocol (FIGO)Preeclampsia (ACOG)Rho(D) Dose (K-B)Rotterdam PCOS CriteriaSyphilis ManagementTORCH FrameworkVBAC Success ProbabilityVulvar Cancer StagingWeight Gain (IOM)mWHO Cardiac Risk
OpiCalc Logo

OpiCalc

Easy, fast, and private medical tools for clinicians. Always free.

No Login Required
Ready for the Bedside

Resources

About UsEditorial PolicyMedical DisclaimerPrivacy PolicyTerms of UseCookie Policy

Support

Contact Us

Clinical Notice:OpiCalc is not a substitute for professional clinical judgment. Always verify dosages and guidelines.

OpiCalc © 2018-2026

•

All Rights Reserved

Specialty Module

Obstetrics and Gynecology

Pregnancy dating, fetal growth assessment, and gynecologic oncology staging.

38

Clinical Tools

6

Clinical Domains

15

Conditions Covered

5

Guidelines Referenced

Clinical Context

Maternal-fetal medicine relies on accurate pregnancy dating, fetal growth assessment, and risk stratification. The APGAR score at 1 and 5 minutes remains the universal standard for newborn assessment, while the Bishop score evaluates cervical favorability for induction of labor.

Preeclampsia screening and diagnosis uses validated clinical criteria including blood pressure thresholds, proteinuria assessment, and maternal risk factors. Early identification and severity stratification guide delivery timing and magnesium sulfate prophylaxis for seizure prevention.

Gynecologic oncology staging follows the FIGO staging systems for cervical, endometrial, ovarian, vulvar, and vaginal cancers. These stages guide surgical planning, radiation therapy, and systemic treatment decisions in accordance with NCCN and ESGO guidelines.

Conditions & Domains

Clinical Conditions Covered

Preeclampsia
Gestational Diabetes
Preterm Labor
Postpartum Hemorrhage
Cervical Cancer
Endometrial Cancer
Ovarian Cancer
Vulvar Cancer
Uterine Fibroids
Endometriosis
PCOS
Infertility
Miscarriage
Ectopic Pregnancy
Gestational Trophoblastic Disease

Evidence Base

Referenced Guidelines & Standards

ACOG Practice Bulletins
NICE Antenatal/Postnatal Guidelines
FIGO Gynecologic Oncology Staging
ESGO Guidelines
WHO Maternal Health Guidelines

Toolkit

38 Clinical Calculators

Peer-Reviewed
APGAR Score
Assisted Delivery (FIGO)
BPP (Manning Score)
Bishop Score
CARPREG II Cardiac Risk
Cervical Cancer Staging
Contraceptive Pearl Index
Doppler Matrix (UA/MCA)
EFW (Hadlock)
Endometrial Staging
Endometrial Thickness
FGR Criteria (Consensus)
FSFI (Sexual Function)
Ferriman-Gallwey Score
Fetal Anemia (MCA PSV)
GDM Diagnostic Criteria
GPA History Indicator
Gail Model Breast Risk
Gestational Dating (LMP)
HIV PMTCT Protocol
IOTA Simple Rules
IVF Due Date & AMH
Iron Deficit (Ganzoni)
Labour Progress (WHO)
Maternal Sepsis (qSOFA)
O-RADS Classification
Ovarian Cancer Staging
PAS Hemorrhage Risk
PPH Protocol (FIGO)
Preeclampsia (ACOG)
Rho(D) Dose (K-B)
Rotterdam PCOS Criteria
Syphilis Management
TORCH Framework
VBAC Success Probability
Vulvar Cancer Staging
Weight Gain (IOM)
mWHO Cardiac Risk

About

Obstetrics and Gynecology

Our OB/GYN suite includes everything from the APGAR and Bishop scores to complex fetal growth models and FIGO staging for gynecologic malignancies.

Covered Areas

  • Maternal-Fetal Risk & Dating
  • Labor Progress & Bishop Score
  • Gynecologic Oncology Staging
  • Preeclampsia & Sepsis in Pregnancy
  • Contraception Guidance
  • Menopause Assessment

All tools are based on published clinical evidence. Results should be interpreted alongside individual patient presentation and current institutional guidelines.